Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
about
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
P2860
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Safety, tolerability and pharm ...... ised placebo-controlled trial.
@en
Safety, tolerability and pharm ...... ised placebo-controlled trial.
@nl
type
label
Safety, tolerability and pharm ...... ised placebo-controlled trial.
@en
Safety, tolerability and pharm ...... ised placebo-controlled trial.
@nl
prefLabel
Safety, tolerability and pharm ...... ised placebo-controlled trial.
@en
Safety, tolerability and pharm ...... ised placebo-controlled trial.
@nl
P2093
P2860
P1433
P1476
Safety, tolerability and pharm ...... mised placebo-controlled trial
@en
P2093
Alejandro Dorenbaum
Andre A van Vliet
Bradley T Keller
Bronislava Gedulin
Ciara A Kennedy
Lisette Acevedo
Melissa Palmer
Nancy Levin
P2860
P2888
P356
10.1186/S12876-017-0736-0
P577
2018-01-05T00:00:00Z
P6179
1100196509